Here are five points:
1. Vertiflex develops minimally invasive interventions for spinal stenosis.
2. Endeavour Vision and H.I.G. BioHealth Partners, both new investors, led the financing round.
3. Existing investors, New Enterprise Associates, Thomas, McNerney & Partners and Alta Partners also led the round.
4. Vertiflex will use most of the funds for the U.S. commercial expansion of the Superion Indirect Decompression System, which is a MIS implant for treating lumbar spinal stenosis.
5. The Superion device, labeled an American Medical Association Current Procedural Terminology Category I code, is designed to decrease pressure on impacted nerves.
More articles on MIS:
Inspired Spine hosts surgeon training for MIS procedures in cadaver lab: 5 highlights
Vertos Medical receives CMS broad coverage approval for mild procedure: 5 key notes
5 notes on bilateral percutaneous fixation in MIS spine surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
